ReviewPharmacy (Basel, Switzerland)2020
Can We Create a Circular Pharmaceutical Supply Chain (CPSC) to Reduce Medicines Waste?
Review in Pharmacy (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Stability and Efficacy of Medicines Beyond Their Expiration Dates: A Systematic Review.Therapeutic innovation & regulatory science · 2026Pooled it
- Managing Inhaler Environmental Sustainability and Effective Respiratory Care: Current Evidence, Challenges, and Opportunities.Pharmaceutical medicine · 2026Article
- The Environmental and Global Impact of Pharmacogenomics: Advancing Green Pharmacy Toward Sustainable and Inclusive Precision Medicine.Journal of personalized medicine · 2026Review
- Patient preferences and attitudes regarding the environmental impact of medicines: A discrete choice experiment.British journal of clinical pharmacology · 2025Article
- Towards eco-friendly pharmaceuticals: Regulatory and policy approaches for sustainable medicines use.Exploratory research in clinical and social pharmacy · 2025Review
- The evolutionary path of medical waste management research: Insights from co-citation and co-word analysis.Waste management & research : the journal of the International Solid Wastes and Public Cleansing Association, ISWA · 2025Review
- Barriers and facilitators to implement the redispensing of unused oral anticancer drugs in clinical care: A hybrid-effectiveness type I study.Exploratory research in clinical and social pharmacy · 2024Article
- Digitalization enhancement in the pharmaceutical supply network using a supply chain risk management approach.Scientific reports · 2023Article
- Domestic Waste and Wastewaters as Potential Sources of Pharmaceuticals in Nestling White Storks (Antibiotics (Basel, Switzerland) · 2023Article
- Examining Knowledge Diffusion in the Circular Economy Domain: a Main Path Analysis.Circular economy and sustainability · 2023Review
- Comparing Environmental Policies to Reduce Pharmaceutical Pollution and Address Disparities.International journal of environmental research and public health · 2022Article
- Medication Use and Storage, and Their Potential Risks in US Households.Pharmacy (Basel, Switzerland) · 2022Article
- Cost-benefit analysis of the integrated pharmaceutical supply chain information service after the establishment of the Korean Pharmaceutical Information Service.Frontiers in pharmacology · 2022Article
- Implementation of the circular supply chain management in the pharmaceutical industry.Environment, development and sustainability · 2022Article
- The Impact of Consequences Awareness of Public Environment on Medicine Return Behavior: A Moderated Chain Mediation Model.International journal of environmental research and public health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe increase in pharmaceutical waste medicines is a global phenomenon and financial burden. The Circular Economy, as a philosophy within the pharmaceutical supply chain, aims to promote waste reduction, maximise medicines value, and enable sustainability within this supply chain (increasing circularity). Circularity strategies for pharmaceuticals are not currently implemented in many countries, due to quality and safety barriers. The aim of this study was to determine whether the application of circular economy principles can minimise pharmaceutical waste and support sustainability in the pharmaceutical supply chain; Methods: a detailed narrative literature review was conducted in order to examine pharmaceutical waste creation, management, disposal, and the application of circular economy principles; Results: the literature scrutinised revealed that pharmaceutical waste is created by multiple routes, each of which need to be addressed by pharmacists and healthcare bodies through the Circular Economy 9R principles. These principles act as a binding mechanism for disparate waste management initiatives. Medicines, or elements of a pharmaceutical product, can be better managed to reduce waste, cost, and reduce negative environmental impacts through unsafe disposal.
conclusionsthe study findings outline a Circular Pharmaceutical Supply Chain and suggests that it should be considered and tested as a sustainable supply chain proposition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.